Cited by 144Autism Spectrum Disorder ResearchSchizophrenia research and treatmentChild Nutrition and Feeding Issues

Risperidone Improves Behavioral Symptoms in Children with Autism in a Randomized, Double-Blind, Placebo-Controlled Trial

Pandina, Gahan J., Bossie, Cynthia A., Youssef, Eriene, Zhu, Young, Dunbar, Fiona·2007·Journal of Autism and Developmental Disorders

Abstract

Subgroup analysis of children (5-12 years) with autism enrolled in an 8-week, double-blind, placebo-controlled trial of risperidone for pervasive developmental disorders. The primary efficacy measure was the Aberrant Behavior Checklist-Irritability (ABC-I) subscale. Data were available for 55 children given risperidone (n=27) or placebo (n=28); mean baseline ABC-I ( +/- SD) was 20.6 (8.1) and 21.6 (10.2). Risperidone [mean dose ( +/- SD): 1.37 mg/day (0.7)] resulted in significantly greater reduction from baseline to endpoint in ABC-I versus placebo [mean change ( +/- SD): -13.4 (1.5) vs. -7.2 (1.4), P<0.05; ES=-0.7]. The most common adverse effect with risperidone was somnolence (74% vs. 7% with placebo). Risperidone treatment was well tolerated and significantly improved behavioral problems associated with autism.

Integrity signals

Registry

Crossref · 10.1007/s10803-006-0234-7

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pandina, G. J., Bossie, C. A., Youssef, E., Zhu, Y., & Dunbar, F.
Affiliations
Janssen Canada (Canada) (CA)
Corresponding author
Pandina, Gahan J.
Venue
Journal of Autism and Developmental Disorders
Published
2006-10-04
Volume
37
Issue
2
Pages
367-373
ISSN
  • 0162-3257 (ISSN-L)
  • 1573-3432
OpenAlex
W2078913169
Cited by
144
References
3
Citations by year
2026: 3 · 2025: 6 · 2024: 8 · 2023: 10 · 2022: 10 · 2021: 5 · 2020: 7 · 2019: 7 · 2018: 10 · 2017: 6 · 2016: 4 · 2015: 5 · 2014: 12 · 2013: 7 · 2012: 11
FWCI
1.62
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Autism and Developmental Disorders (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
Keywords
risperidone, autism spectrum disorder, pervasive developmental disorders, irritability, Aberrant Behavior Checklist, behavioral symptoms, children, antipsychotic drugs, sleepiness, adverse effects
MeSH terms
Autistic Disorder, Child, Child, Preschool, Double-Blind Method, Female, Humans, Male, Psychomotor Disorders, Antipsychotic Agents, Treatment Outcome, Risperidone, Mood Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review